| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
N/A |
| Shares
Out: |
26,519,000 |
| Market
Cap: |
18.78(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.55 - $1.72 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile VolitionRx is an epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop blood tests to help diagnose and monitor a range of life-altering diseases including certain cancers and diseases associated with NETosis such as sepsis and COVID-19. Co.'s tests are based on the science of Nucleosomics™, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Co. is primarily focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
10,000 |
200,422 |
928,911 |
| Total Buy Value |
$0 |
$8,300 |
$194,762 |
$1,588,869 |
| Total People Bought |
0 |
1 |
11 |
12 |
| Total Buy Transactions |
0 |
1 |
20 |
37 |
| Total Shares Sold |
0 |
20,000 |
40,000 |
40,000 |
| Total Sell Value |
$0 |
$18,000 |
$33,000 |
$33,000 |
| Total People Sold |
0 |
1 |
1 |
1 |
| Total Sell Transactions |
0 |
1 |
2 |
2 |
| End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Innes Guy Archibald |
Director |
– • – |
2015-02-11 |
4 |
B |
$3.75 |
$187,500 |
D/D |
50,000 |
1,170,197 |
2.39 |
- |
|
| Colman Alan |
Director |
– • – |
2014-09-24 |
4 |
B |
$7,000.00 |
$22,274,000 |
D/D |
3,182 |
53,937 |
2.39 |
- |
|
| Innes Guy Archibald |
Director |
– • – |
2014-09-24 |
4 |
B |
$18,748.40 |
$159,773,865 |
D/D |
8,522 |
1,120,197 |
2.39 |
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2014-09-15 |
4 |
B |
$2.16 |
$10,800 |
D/D |
5,000 |
1,041,067 |
2.39 |
- |
|
| Faulkes Martin Charles |
Director |
– • – |
2014-09-03 |
4 |
GA |
$0.00 |
$0 |
D/D |
110,000 |
1,036,067 |
|
- |
|
| Reynolds Cameron John |
CEO and President |
• • • |
2014-09-03 |
4 |
S |
$0.00 |
$0 |
I/I |
(1,038,000) |
1,004,088 |
|
- |
|
| Reynolds Cameron John |
CEO and President |
• • • |
2014-09-03 |
4 |
GA |
$0.00 |
$0 |
D/D |
900,000 |
1,102,344 |
|
- |
|
| Concord International Inc. |
Secretary |
– – • |
2014-09-03 |
4 |
S |
$1.80 |
$50,400 |
I/I |
(28,000) |
1,004,088 |
|
- |
|
| Concord International Inc. |
Secretary |
– – • |
2014-09-03 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,010,000 |
1,010,088 |
|
- |
|
| Skaff Habib |
Director |
– • – |
2014-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,580 |
|
- |
|
| Innes Guy Archibald |
Director |
– • – |
2014-03-10 |
4 |
B |
$4,206.72 |
$1,795,652,303 |
I/I |
42,456 |
1,111,675 |
2.1 |
- |
|
| Innes Guy Archibald |
Director |
– • – |
2013-12-02 |
4 |
B |
$9,999.90 |
$48,779,512 |
D/D |
4,878 |
1,069,219 |
2.39 |
- |
|
| Innes Guy Archibald |
Director |
– • – |
2013-11-25 |
4 |
B |
$271,103.00 |
$2,147,483,647 |
D/D |
132,246 |
1,064,341 |
2.39 |
- |
|
| Innes Guy Archibald |
Director |
– • – |
2013-11-14 |
4 |
B |
$1,898.10 |
$40,681,863 |
D/D |
5,877 |
932,095 |
2.39 |
- |
|
| Colman Alan |
Director |
– • – |
2013-08-16 |
5 |
A |
$2.25 |
$7,002 |
D/D |
3,112 |
50,755 |
|
- |
|
| Innes Guy Archibald |
Director |
– • – |
2013-03-25 |
4 |
B |
$114,583.00 |
$2,147,483,647 |
D/D |
57,292 |
926,218 |
2.39 |
- |
|
| Magallano Alexander B. |
Chief Executive OfficerOfficer |
• • – |
2008-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| Perez Rudy Belloy |
Treasurer & SecretaryOfficer |
• – – |
2008-04-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| Thachuk E Del |
CEO and President |
• • – |
2005-09-30 |
4 |
B |
$0.05 |
$5,000 |
D/D |
100,000 |
100,000 |
2.81 |
- |
|
| Thachuk Mary Anne |
Secretary Treasurer |
• – – |
2005-09-30 |
4 |
B |
$0.05 |
$1,000 |
D/D |
20,000 |
20,000 |
2.66 |
- |
|
| Brooke Brian Gordon |
Chief Financial Officer |
• • – |
2005-09-30 |
4 |
B |
$0.05 |
$2,500 |
D/D |
50,000 |
50,000 |
2.73 |
- |
|
321 Records found
|
|
Page 13 of 13 |
|
|
0.03 (4.89%) 
